Related Experiment Video
Updated: Nov 2, 2025

Author Spotlight: Evaluating Traditional Chinese Therapy for Ankylosing Spondylitis in Mice
Published on: October 27, 2023
Moxibustion Protects Dopaminergic Neurons in Parkinson's Disease through Antiferroptosis
Zifeng Huang1,2, Wenwen Si1, Xinrong Li1,2
1Traditional Chinese Medicine Innovation Research Center, Shenzhen Hospital of Integrated Traditional Chinese and Western Medicine, Shenzhen, Guangdong 518104, China.
Abstract:
Ferroptosis is associated with neural degeneration of dopaminergic neurons in Parkinson's disease (PD). However, how to control the level of ferroptosis in PD remains unclear. Clinically, moxibustion has been used to treat PD and has an apparent therapeutic effect on improving the motor symptoms of PD. In the present study, the PD rat model was constructed by two-point stereotactic 6-hydroxydopamine injection. Then, moxibustion was used to treat the PD rats. The expression of glutathione peroxidase 4 (GPX4) and Ferritin Heavy Chain 1 (FTH1), the level of reactive oxygen species (ROS), and the morphology of mitochondrial were detected to evaluate the level of ferroptosis. The results showed that moxibustion treatment of Shi's moxa sticks could reduce the behavioral score, alleviate the level of ferroptosis, decrease mitochondrial damage, and improve dopaminergic neuron survival. In conclusion, the present study results indicated that Shi's moxa sticks could effectively suppress the level of ferroptosis, thereby improving the survival of dopaminergic neurons in the SNpc of PD rats, which may provide a promising complementary and alternative therapy for PD patients.
Insights
Moxibustion treatment effectively reduces ferroptosis, a key factor in Parkinson's disease (PD) neurodegeneration. This therapy improves motor symptoms and dopaminergic neuron survival in PD rats, offering a potential alternative treatment.
Area of Science:
- Neuroscience
- Biochemistry
- Traditional Chinese Medicine
Background:
- Ferroptosis, a form of regulated cell death, is increasingly linked to dopaminergic neuron loss in Parkinson's disease (PD).
- The precise mechanisms controlling ferroptosis in PD pathogenesis and effective therapeutic interventions remain areas of active investigation.
- Moxibustion, a traditional Chinese medicine technique, is clinically observed to ameliorate PD motor symptoms, suggesting a potential role in modulating disease processes.
Purpose of the Study:
- To investigate the efficacy of moxibustion in modulating ferroptosis and its impact on dopaminergic neuron survival in a rat model of Parkinson's disease.
- To evaluate the effects of moxibustion on key ferroptosis markers, including glutathione peroxidase 4 (GPX4), Ferritin Heavy Chain 1 (FTH1), reactive oxygen species (ROS) levels, and mitochondrial morphology.
Main Methods:
- A Parkinson's disease rat model was established using stereotactic injection of 6-hydroxydopamine.
- PD rats were treated with moxibustion using Shi's moxa sticks.
- Ferroptosis levels were assessed by measuring GPX4 and FTH1 expression, ROS generation, and mitochondrial ultrastructure.
Main Results:
- Moxibustion treatment significantly reduced behavioral scores in PD rats.
- The therapy effectively alleviated the level of ferroptosis, evidenced by decreased ROS and improved mitochondrial morphology.
- Moxibustion treatment promoted the survival of dopaminergic neurons in the substantia nigra pars compacta (SNpc).
Conclusions:
- Shi's moxa sticks demonstrate a significant capacity to suppress ferroptosis in the context of Parkinson's disease.
- Moxibustion therapy improves dopaminergic neuron survival and motor function in PD rats, likely by mitigating ferroptosis.
- These findings suggest moxibustion holds promise as a complementary and alternative therapy for Parkinson's disease patients.
Related Concept Videos
Parkinson's Disease: Treatment
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease: Overview
Drugs Affecting Neurotransmitter Synthesis
Neural Regulation
Indirect-Acting Cholinergic Agonists: Pharmacological Actions
At the neuromuscular junction, these agents work by inhibiting the breakdown of acetylcholine, allowing it to remain bound to the receptor and bind to nearby receptors. This process leads to repetitive firing of the endplate, causing muscle...

